[
    [
        {
            "time": "",
            "original_text": "医药投向标|福建第二轮集采纳入生物制品微医正式向港交所提交上市申请生物医药企业年报披露潮",
            "features": {
                "keywords": [
                    "医药",
                    "福建",
                    "第二轮集采",
                    "生物制品",
                    "微医",
                    "港交所",
                    "上市申请",
                    "生物医药企业",
                    "年报披露"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药投向标|福建第二轮集采纳入生物制品微医正式向港交所提交上市申请生物医药企业年报披露潮",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]